Author:
Koltsova A. M.,Zenin V. V.,Petrosyan M. A.,Turilova V. I.,Yakovleva T. K.,Poljanskaya G. G.
Reference47 articles.
1. Abedian, Z., Jenabian, N., Moghadamnia, A.A., Zabihi, E., Pourbagher, R., and Hossein-Nataj, H., A comparative study on immunophenotypic characterization and osteogenic differentiation of human mesenchymal stromal cells derived from periodontal ligament and gingival, J. Periodontol., 2020. https://doi.org/10.1002/JPER.19-0535
2. Ali, H., Al-Yatama, M.K., Abu-Farha, M., Behbe-hani, K., and Al Madhoun, A., Multi-lineage differentiation of human umbilical cord Wharton’s jelly mesenchymal stromal cells mediates changes in the expression profile of stemness markers, PLoS One, 2015, vol. 10, e0122465. https://doi.org/10.1371/journal.pone.0122465
3. An International System for Human Cytogenetic Nomenclature, Shaffer, I.G., Slovak, M.L., and Campbell, L.J., Eds., Basel: Karger, 2013.
4. Antonucci, I., Stuppia, L., Kaneko, Y., Yu, S., Tajiri, N., Bae, E.C., Chheda, S.H., Weinbren, N.L., and Borlongan, C.V., Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy, Cell Transplantol., 2011, vol. 20, p. 789.
5. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., Lantz, O., Mačiulaitis, R., Palomäki, T., Schneider, C.K., Sensebé, L., Tachdjian, G., Tarte, K., Tosca, L., and Salmikangas, P., Risk of tumorigenicity in mesenchymal stromal cell-based therapies—bridging scientific observations and regulatory viewpoints, Cytotherapy, 2013, vol. 15, p. 753.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献